Building on our foundation in self-amplifying RNA, we have developed amplified circular RNA (acRNA)-a new class of RNA technology that unites amplification and circularization in a single, more powerful platform. acRNA opens a new design space for precision RNA programming, creating new possibilities for how RNA medicines are engineered and deployed.

This advance marks the next chapter for Chimeron Bio and a new identity: ACIRNA Therapeutics.

Our mission remains the same: developing first- and best-in-class RNA therapeutics engineered to reprogram the immune system against cancer and autoimmune disease.